Publication | Closed Access

Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy

Tubb3 ExpressionMedicineCancer Cell BiologyPathologyPredictive ValueFirst-line Platinum–paclitaxel ChemotherapyBronchial NeoplasmCancer TreatmentOncologyCell BiologyLung CancerTumor Biology